Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market
Private equity reduces patient care while enriching investors, Senate report finds
J&J says its lung cancer drug combination keeps people alive longer
Hims & Hers donates $1 million to Trump's inauguration fund
U.S. records its first human bird flu death
Many Parts Therapy Empowers Individuals to Heal and Thrive Through Compassionate Trauma-Informed Care
U.S. surgeon general calls for cancer risk warnings on alcohol labels
